Quick summary: Ozempic (semaglutide) is a once-weekly injectable GLP-1 receptor agonist originally approved for type 2 diabetes that has demonstrated meaningful weight loss in clinical trials. It works by slowing digestion and reducing appetite signals in the brain. It is a prescription medication with real risks and contraindications — including a boxed warning related to thyroid tumors — and is not appropriate for everyone. Candidacy is determined at a medical consultation. Individual results vary.
Medically reviewed by the clinical team at OC Weight Loss & Med Spa. Last updated: June 12, 2026.
What Is Ozempic?
Ozempic is the brand name for semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist manufactured by Novo Nordisk. The FDA approved it in 2017 for the treatment of type 2 diabetes in adults. A higher-dose formulation of the same active ingredient — branded as Wegovy — was subsequently approved specifically for chronic weight management.
GLP-1 is a hormone your body produces naturally in response to eating. It signals the pancreas to release insulin, slows the rate at which the stomach empties, and communicates with appetite-regulating centers in the brain. Semaglutide mimics this hormone. The result is a meaningful reduction in appetite and caloric intake for many patients.
How Ozempic Supports Weight Loss
Ozempic supports weight loss through several overlapping mechanisms:
- Slowed gastric emptying. Food leaves the stomach more slowly, which prolongs the feeling of fullness after meals.
- Reduced appetite signaling. The drug acts on receptors in the hypothalamus, the brain region that regulates hunger and satiety, leading many patients to feel less driven to eat.
- Lower fasting and post-meal blood glucose. Stabilized blood sugar reduces the spikes and crashes that can trigger cravings.
In clinical trials, participants using semaglutide alongside lifestyle changes lost substantially more weight than those on placebo, with average losses in the range of 10–15% of body weight over approximately 68 weeks. Results vary depending on starting weight, adherence, diet, and activity level.
Who May Be a Candidate
At OC Weight Loss & Med Spa in Mission Viejo, every patient considering Ozempic or semaglutide-based therapy starts with a thorough medical consultation. Ozempic is typically considered for adults who:
- Have a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or elevated cholesterol.
- Have not achieved adequate results through diet and exercise alone.
- Do not have contraindications (see safety section below).
Whether a patient has type 2 diabetes or not, candidacy is evaluated on an individual basis. A provider reviews medical history, current medications, and personal goals before any prescription is written.
What to Expect During Treatment
Ozempic is administered as a subcutaneous injection, typically in the abdomen, thigh, or upper arm, once per week. Treatment usually begins at a low dose (0.25 mg) and is titrated upward over several weeks to minimize side effects and allow the body to adjust.
Most patients do not see dramatic weight changes in the first few weeks. The medication is intended as a long-term tool, used alongside dietary changes and increased physical activity. Patients who stop taking GLP-1 medications often experience weight regain, which is why the broader treatment plan — including sustainable lifestyle habits — matters as much as the medication itself.
At OC Weight Loss & Med Spa, Lindsay Short, NP, oversees medical weight loss patients. Lindsay is a board-certified Nurse Practitioner (UCLA chemistry BS, Columbia MSN), and the clinic is physician-supervised by Dr. Nezar Dahdal, MD, board certified in Internal Medicine. Patients receive individualized guidance rather than a one-size-fits-all protocol.
Safety, Side Effects, and Who Should Not Use Ozempic
Ozempic carries a boxed warning — the FDA’s most serious label designation — regarding thyroid C-cell tumors. In rodent studies, semaglutide caused thyroid C-cell tumors at clinically relevant exposures. It is unknown whether this risk applies to humans. For this reason, Ozempic is contraindicated in patients with:
- A personal or family history of medullary thyroid carcinoma (MTC)
- Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Additional contraindications and precautions include:
- Pregnancy and breastfeeding. Ozempic should be discontinued at least two months before a planned pregnancy. It is not approved for use during pregnancy.
- Personal history of pancreatitis. GLP-1 receptor agonists have been associated with pancreatitis in some patients. Patients with a history of pancreatitis should discuss the risk carefully with their provider.
- Severe gastrointestinal disease. Because Ozempic slows gastric emptying, it may worsen certain GI conditions such as gastroparesis.
- Diabetic retinopathy. Rapid improvement in blood sugar control with semaglutide has been associated with temporary worsening of diabetic retinopathy in some patients.
Common side effects, particularly during dose escalation, include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These typically improve over time. Serious but less common side effects include acute pancreatitis, gallbladder disease, and severe allergic reactions.
Candidacy for Ozempic is always determined at a medical consultation. Self-prescribing or using compounded semaglutide from unregulated sources carries significant safety risks.
Frequently Asked Questions
Can someone without diabetes use Ozempic for weight loss?
Yes, a provider may prescribe semaglutide off-label to patients without diabetes who meet weight-related criteria. Wegovy, the higher-dose semaglutide formulation, is FDA-approved specifically for chronic weight management regardless of diabetes status. A medical consultation determines which formulation and approach is appropriate for each patient.
How much weight can I expect to lose?
In clinical trials, patients on semaglutide combined with lifestyle intervention lost an average of approximately 10–15% of their body weight over roughly 16 months. Individual results vary significantly based on starting weight, adherence to dietary guidance, physical activity, and other health factors. Weight loss is not guaranteed.
What happens if I stop taking Ozempic?
Clinical data shows that most patients regain a substantial portion of lost weight after discontinuing semaglutide. This reflects the chronic nature of obesity as a medical condition. Long-term success generally depends on maintaining the lifestyle habits built during treatment. Your provider can help create a plan for transitioning off the medication when the time is right.
Is Ozempic covered by insurance?
Coverage varies by plan and diagnosis. Insurance is more likely to cover Ozempic when it is prescribed for type 2 diabetes than for weight management alone. OC Weight Loss & Med Spa offers financing options through Cherry and CareCredit to help patients manage out-of-pocket costs. Our team can discuss cost and coverage at your consultation.
How is Ozempic different from other weight loss medications?
Ozempic belongs to the GLP-1 receptor agonist class, which works differently from older weight loss medications such as phentermine (a stimulant that suppresses appetite centrally) or orlistat (which blocks fat absorption). GLP-1 receptor agonists address multiple pathways simultaneously — appetite, digestion, and blood sugar — and have a well-studied cardiovascular safety profile. The best medication for any individual depends on their full health picture, which a provider evaluates at consultation.
Schedule a Consultation at OC Weight Loss & Med Spa
If you are considering Ozempic or another medically supervised weight loss approach, the first step is a consultation with a qualified provider. At OC Weight Loss & Med Spa in Mission Viejo, Lindsay Short, NP, works with each patient to evaluate health history, discuss realistic expectations, and build a personalized plan. The clinic is located at 24002 Via Fabricante #201, Mission Viejo, CA 92691, and can be reached at (949) 416-0950. Office hours are Monday through Friday, 9 a.m. to 5 p.m., and Saturday, 9 a.m. to 1 p.m.
Book a free consultation
Book a Free Consultation